Biotage

Declaration of Voting Results & Voting Rights Announcements • Sep 30, 2024

Change in number of shares and votes

As previously announced, Biotage AB (publ) ("Biotage") has during September 2024 issued 286,440 new class C shares in accordance with the incentive program LTIP 2024 which was adopted by the Annual General Meeting held on April 25, 2024.

Prior to the issue, the total number of shares and votes in Biotage amounted to 80,667,695. Through the issue the number of shares in Biotage has increased by 286,440 shares, corresponding to 28,644.0 votes. As of today, the total number of registered shares of Biotage amount to 80,954,135, whereof 80,049,272 are ordinary shares and 904,863 are class C shares. As of today, the number of votes in Biotage amount to 80,139,758.3, and the registered share capital amounts to SEK 112,526,247.65.

Contacts

Frederik Vanderhagen, President and CEO

Andrew Kellett, CFO

e: ir@biotage.com

About Biotage

Biotage is the Global Go-To Separations Company, supporting customers from drug discovery and development through to diagnostics and analytical testing with intelligent and sustainable workflow solutions. Our expertise and top-tier separation solutions play a key role in streamlining our customers' workflows and improving their outcomes.

Headquartered in Sweden, Biotage operates globally with 700 employees, serving over 80 countries. Our company is listed on NASDAQ Stockholm (BIOT).

Website: www.biotage.com

This information is information that Biotage is obliged to make public pursuant to the Financial Instruments Trading Act. The information was submitted for publication at 2024-09-30 17:00 CEST.

Attachments

Change in number of shares and votes